Citation 82680

FUJIOKA,T: FURUMI,K: FUJII,H: OKABE,H: MIHASHI,K: NAKANO,Y: MATSUNAGA,H: KATANO,M: MORI,M:. (1999). ANTIPROLIFERATIVE CONSTITUENTS FROM UMBELLIFERAE PLANTS. V. A NEW FURANOCOUMARIN AND FALCARINDIOL FURANOCOUMARIN ETHERS FROM THE ROOT OF ANGELICA JAPONICA.. 47(1)

Citation Details

Title	ANTIPROLIFERATIVE CONSTITUENTS FROM UMBELLIFERAE PLANTS. V. A NEW FURANOCOUMARIN AND FALCARINDIOL FURANOCOUMARIN ETHERS FROM THE ROOT OF ANGELICA JAPONICA.
Authors	FUJIOKA,T: FURUMI,K: FUJII,H: OKABE,H: MIHASHI,K: NAKANO,Y: MATSUNAGA,H: KATANO,M: MORI,M:
Year	1999
Volume	47
Issue	1

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Angelica japonica (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
3	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FALCARINOL	None
4	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINOL	STRONG ACTIVITY
5	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINOL	INACTIVE
6	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINOL	EQUIVOCAL
7	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	OSTHOL	None
8	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	INACTIVE
9	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	INACTIVE
10	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	INACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FALCARINDIOL,8-O-ACETYL:	None
12	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL,8-O-ACETYL:	ACTIVE
13	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL,8-O-ACETYL:	WEAK ACTIVITY
14	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL,8-O-ACETYL:	WEAK ACTIVITY
15	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	IMPERATORIN,ISO:	None
16	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN,ISO:	INACTIVE
17	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN,ISO:	INACTIVE
18	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN,ISO:	EQUIVOCAL
19	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SCOPOLETIN	None
20	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPOLETIN	INACTIVE
21	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPOLETIN	INACTIVE
22	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SCOPOLETIN	WEAK ACTIVITY
23	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	BYAKANGELICIN	None
24	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BYAKANGELICIN	INACTIVE
25	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BYAKANGELICIN	INACTIVE
26	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BYAKANGELICIN	INACTIVE
27	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	XANTHOTOXIN	None
28	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXIN	INACTIVE
29	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXIN	WEAK ACTIVITY
30	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOTOXIN	EQUIVOCAL
31	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	BERGAPTEN	None
32	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	EQUIVOCAL
33	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	WEAK ACTIVITY
34	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BERGAPTEN	INACTIVE
35	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	JAPOANGELONE	None
36	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELONE	EQUIVOCAL
37	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELONE	EQUIVOCAL
38	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELONE	WEAK ACTIVITY
39	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PEUCEDANIN,OXY: METHANOLATE	None
40	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	EQUIVOCAL
41	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	INACTIVE
42	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	WEAK ACTIVITY
43	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PEUCEDANIN,OXY: HYDRATE	None
44	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	EQUIVOCAL
45	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	INACTIVE
46	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	EQUIVOCAL
47	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	JAPOANGELOL A	None
48	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL A	WEAK ACTIVITY
49	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL A	WEAK ACTIVITY
50	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL A	WEAK ACTIVITY
51	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	JAPOANGELOL B	None
52	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL B	ACTIVE
53	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL B	WEAK ACTIVITY
54	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL B	WEAK ACTIVITY
55	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	JAPOANGELOL C	None
56	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL C	WEAK ACTIVITY
57	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL C	WEAK ACTIVITY
58	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL C	WEAK ACTIVITY
59	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	JAPOANGELOL D	None
60	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL D	WEAK ACTIVITY
61	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL D	WEAK ACTIVITY
62	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JAPOANGELOL D	EQUIVOCAL
63	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	HAMAUDOL,3'-O-ACETYL:	None
64	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL,3'-O-ACETYL:	INACTIVE
65	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL,3'-O-ACETYL:	INACTIVE
66	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL,3'-O-ACETYL:	EQUIVOCAL
67	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FALCARINDIOL	None
68	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL	ACTIVE
69	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL	EQUIVOCAL
70	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FALCARINDIOL	WEAK ACTIVITY
71	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	HAMAUDOL	None
72	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL	INACTIVE
73	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL	INACTIVE
74	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAMAUDOL	INACTIVE
75	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CAFFEIC ACID METHYL ESTER	None
76	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID METHYL ESTER	ACTIVE
77	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID METHYL ESTER	ACTIVE
78	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID METHYL ESTER	ACTIVE
79	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	HEPTADECA-1-CIS-9-DIENE-4-6-DIYNE-3-8-11-TRIOL	None
80	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTADECA-1-CIS-9-DIENE-4-6-DIYNE-3-8-11-TRIOL	ACTIVE
81	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTADECA-1-CIS-9-DIENE-4-6-DIYNE-3-8-11-TRIOL	EQUIVOCAL
82	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTADECA-1-CIS-9-DIENE-4-6-DIYNE-3-8-11-TRIOL	WEAK ACTIVITY
83	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTEROL	None

Citation 82680

Citation Details

Summary

Organisms and Their Experiments (1)

Angelica japonica (APIACEAE)

Show SPARQL Queries (1)

Query 1